MD Biosciences inflammation services

Newsletter

Target Inflammation:
A prectical applications newsletter for inflammations and neurology research.

Register


Proposals

Get Proposal

Interested in validating a custom assay?
Speak to a scientist. 


Related Assays

Gene Expression Biomarker Analysis
Imaging
Histology

Preclinical efficacy testing in models of Inflammation

MD Biosciences Inflammations Discovery Services provides a wide range of research services spanning in vitro and in vivo evaluation of compounds, mode of action work, as well as efficacy in disease models.

Benefits to working with the Inflammations Discovery Services Group at MD Biosciences:

  • Quick start dates and timely delivery of data
  • All scientists are specialized and have experience with small molecules and biologicals
  • Standard and specialized routes of administration
  • Customized protocols
  • Development of novel models

Preclinical capabilities include:

  • Efficacy studies in several therapeutic areas
  • Mode of Action Platforms
  • Bioanalysis using immunoassay techniques
  • Gene Expression analysis
  • Histopathology processing and/or scoring
  • Imaging capabilities

 

Therapeutic Areas:

Arthritis

Respiratory

Inflammatory Bowel Disease (IBD)

Type I Diabetes

Endotoxic Shock

Contact Dermatitis

Multiple Sclerosis (EAE)

Inflammatory & Arthritic Pain

Interesting Fact

Multiple Sclerosis is a lifelong ailment that affects more than 400,000 Americans, resulting in an earning loss of about $10.6 billion annually for U.S. families with MS.

Client Testimonial

“Among all the CROs that I have used over the years, including recently for inflammation, MD Biosciences has been one of the very best in terms of scientific knowledge, expertise, data quality, timelines, flexibility and personal contacts.”

O.B., Director of Preclinical Research Pharmaceutical Company